Ruth Tachezy, PhD.

1 in Phase 3

Quick facts

Phase 3 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Ruth Tachezy, PhD.

What is Ruth Tachezy, PhD.'s pipeline?

Ruth Tachezy, PhD. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Silgard.

Related